For the second straight quarter, Teva Pharmaceutical Industries (NYSE: TEVA) stock is getting the Buffett bump. Teva shares jumped nearly 4 percent Wednesday morning after the latest filing from Warren Buffett’s Berkshire Hathaway …
Load Error It operates in three areas — Complex Generics, Biosimilars and Novel Therapeutics. The company markets Glatopa, a generic version of Teva’s TEVA …
Warren Buffett, the billionaire investor and famed Oracle of Omaha, saw the stock portfolio of his Berkshire Hathaway decline by about $2 billion in Q1, according to …
It's unclear if Buffett himself is behind the growing Teva stake, or if it is an …
Deteriorating credit metrics could lead to additional debt downgrades, hurting sentiment for the stock. Teva delivered a solid Q1, but things will likely get worse for Copaxone sales, cash flow and the stock. Sell TEVA. Disclosure: I am/we are …
Basel, Switzerland headquartered Novartis AG's stock finished Thursday's session 0.58% lower at $77.15 with a total …
In a regulatory filing detailing Berkshire’s U.S.-listed stock holdings as of March …
The announcement shot Teva’s share price up by nearly 5 percent in after-hours trading. The price dipped slightly when Buffett announced that he had not …